CRH Medical Corp (TSE:CRH) – Research analysts at Cormark lifted their Q1 2018 earnings estimates for shares of CRH Medical Corp in a research report issued to clients and investors on Friday. Cormark analyst D. Novak now expects that the company will earn $0.05 per share for the quarter, up from their previous forecast of $0.04. Cormark also issued estimates for CRH Medical Corp’s Q3 2018 earnings at $0.06 EPS and FY2018 earnings at $0.23 EPS.

TRADEMARK VIOLATION WARNING: “Q1 2018 EPS Estimates for CRH Medical Corp Lifted by Cormark (TSE:CRH)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/09/q1-2018-eps-estimates-for-crh-medical-corp-lifted-by-cormark-tsecrh.html.

CRH has been the topic of a number of other research reports. TD Securities cut their price objective on shares of CRH Medical Corp from C$12.00 to C$10.50 and set a “buy” rating on the stock in a report on Friday, July 7th. Scotiabank cut their price objective on shares of CRH Medical Corp from C$7.00 to C$6.75 and set an “outperform” rating on the stock in a report on Thursday, August 3rd. Royal Bank Of Canada cut their price objective on shares of CRH Medical Corp from C$8.50 to C$6.00 and set an “outperform” rating on the stock in a report on Friday, July 21st. Finally, National Bank Financial cut their price objective on shares of CRH Medical Corp from C$7.00 to C$5.25 and set an “outperform” rating on the stock in a report on Thursday, August 3rd. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. CRH Medical Corp currently has a consensus rating of “Buy” and a consensus target price of C$6.75.

CRH Medical Corp (TSE:CRH) traded down 3.75% during trading on Monday, reaching $2.82. The company had a trading volume of 724,149 shares. The stock has a 50 day moving average price of $5.84 and a 200-day moving average price of $8.36. CRH Medical Corp has a 52-week low of $2.67 and a 52-week high of $12.35. The company has a market capitalization of $208.45 million and a PE ratio of 23.11.

In other news, Director David Johnson sold 30,000 shares of the business’s stock in a transaction dated Wednesday, June 28th. The shares were sold at an average price of C$5.67, for a total value of C$170,100.00.

CRH Medical Corp Company Profile

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Earnings History and Estimates for CRH Medical Corp (TSE:CRH)

Receive News & Stock Ratings for CRH Medical Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical Corp and related stocks with our FREE daily email newsletter.